Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic,
surgically unresectable disease. Although the goal of early detection of PDAC is laudable …

Body composition, defined as the proportions and distribution of lean and fat tissues in the
human body, is an emergent theme in clinical oncology. Severe muscle depletion …

Background The optimal nutritional therapy in the field of pancreatic surgery is still debated.
Methods An international panel of recognized pancreatic surgeons and pancreatologists …

Backround The role of sarcopenia and sarcopenic obesity in patients with pancreatic ductal
adenocarcinoma (PDAC) remains controversial. Material and Methods Medline and Web of …

Background Cancer cachexia and skeletal muscle wasting are related to poor survival. In
this study, quantitative body composition measurements using computed tomography (CT) …

Introduction Pancreatic and periampullary adenocarcinomas are associated with abnormal
body composition visible on CT scans, including low muscle mass (sarcopenia) and low …

The recent publication of new surgical nutrition guidelines, the PONS score, and use of LBM
assessments will allow better identification and earlier intervention on perioperative …

Background Sarcopenia and post‐operative accelerated muscle loss leading to cachexia
are commonly observed in patients with pancreatic cancer. This study aimed to assess the …

Importance Sarcopenia and sarcopenic obesity have been associated with poor outcomes
in unresectable pancreatic cancer (PC). Neoadjuvant treatment (NT) is used increasingly to …

Background The association between sarcopenia and postoperative outcomes has been
well reported. However, the impact of different sarcopenia stages on postoperative …